Richard Lehman’s journal review – 17 October 2011

JAMA   12 Oct 2011  Vol 306 1549    It has been a bad week for vitamin supplements. Worst hit, as usual, has been vitamin E. The SELECT trial began collecting 35 000+ healthy men with normal feeling prostates back in 2001 and randomised them to get a selenium supplement, a vitamin E supplement, both, or placebo. […]

Read More…

Richard Lehman’s journal review – 10 October 2011

JAMA  5 Oct 2011  Vol 306 1461    American medicine is a mass of quirks and contradictions: like medicine anywhere else, but magnified by huge financial forces pulling in different directions. There is a big financial incentive for cardiologists to do percutaneous interventions in elderly patients with stable coronary disease, for example, though the evidence suggests […]

Read More…

Richard Lehman’s journal review – 3 October 2011

JAMA  28 Sep 2011  Vol 306 1329    Intra-aortic balloon counterpulsation reduces left ventricular load and improves outcomes in animal models of myocardial infarction. But in previous small human studies of MI without shock, it hasn’t been shown to do anything much, and this trial confirms that it does not reduce infarct size significantly. But such […]

Read More…

Richard Lehman’s journal review – 26 September 2011

JAMA  21 Sep 2011  Vol 306 1205   I don’t know why spammers have me down as so interested in imitation Rolex watches and erectile function: neither is particularly true. But I guess that if I had a diagnosis of localised prostate cancer, I might want to know the chances of each treatment option causing me […]

Read More…

Richard Lehman’s journal review – 19 September 2011

JAMA  14 Sep 2011  Vol 306 1089   In medicine, always expect the counterintuitive. For some time it has been known that removing more lymph nodes at the time of bowel cancer surgery is associated with better outcomes. This is nicely confirmed in this large cohort study – 86 394 patients, showing a one third reduction […]

Read More…

Richard Lehman’s journal review – 12 September 2011

JAMA  7 Sep 2011  Vol 306 952   This is a themed issue on Medical Education, a domain where giant forces compete for the minds of highly selected young people, and science can tell us little about what really matters. I gave my first talk on the subject in 1973, to a largely female student audience […]

Read More…

Richard Lehman’s journal review – 5 September 2011

NEJM  1 Sep 2011  Vol 365 787    Studies of out-of-hospital cardiac arrest require heroic feats of organization and generally provide survival-to-discharge rates around 7%. In this randomized trial, the research question was whether in a person found pulseless out of hospital, it’s best to start CPR immediately or to analyze the heart rhythm immediately. In […]

Read More…

Richard Lehman’s journal review – 30 August 2011

JAMA  24-31 Aug 2011  Vol 306 840   Every GP knows that some patients who are admitted to hospital come out without their usual medication and take this as an indication that they don’t need it any more. This happens particularly after admission to ICU. The team doing this cohort study in Ontario makes an attempt […]

Read More…

Richard Lehman’s journal review – 23 August 2011

JAMA  17 Aug 2011  Vol 306 711   Randomized controlled trials of new interventions have become something of a rarity in JAMA of late, so I was interested to see this account of two industry-funded trials of pegloticase, a genetically engineered uricase designed to lower uric acid in people with treatment-resistant gout. This drug already has […]

Read More…